|
Pronunciation |
|
(e
RI thri til te tra NYE
trate) |
|
|
U.S. Brand
Names |
|
Cardilate® |
|
|
Generic
Available |
|
No |
|
|
Pharmacological Index |
|
Vasodilator |
|
|
Use |
|
Prophylaxis and long-term treatment of frequent or recurrent anginal pain and
reduced exercise tolerance associated with angina pectoris |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Contraindications |
|
Hypersensitivity to erythrityl tetranitrate or any component; severe anemia;
angle-closure glaucoma; postural hypotension; cerebral hemorrhage; head
trauma |
|
|
Warnings/Precautions |
|
Use with caution in patients with hypertrophic cardiomyopathy, in patients
with glaucoma, or volume depletion; tolerance may develop |
|
|
Adverse
Reactions |
|
>10%: Central nervous system: Headache
1% to 10%: Cardiovascular: Tachycardia, hypotension, flushing
<1% (Limited to important or life-threatening symptoms): Restlessness,
dizziness, nausea, vomiting, diarrhea, methemoglobinemia, weakness
|
|
|
Drug
Interactions |
|
Sildenafil: Significant reduction of systolic and diastolic blood pressure
with concurrent use. Do not give sildenafil within 24 hours of a nitrate
preparation. |
|
|
Mechanism of
Action |
|
Erythrityl tetranitrate, like other organic nitrates, induces vasodilation by
dephosphorylation of the myosin light chain in smooth muscles. This is
accomplished by activation of guanylate cyclase, which eventually stimulates a
cyclic GMP-dependent protein kinase that alters the phosphorylation of the
myosin. Venodilation causes peripheral blood pooling, which decreases venous
return to the heart, central venous pressure, and pulmonary capillary wedge
pressure. A reduction in pulmonary vascular resistance occurs secondary to
pulmonary arteriolar dilation and afterload may be decreased by a lowering of
systemic arterial pressure. |
|
|
Usual Dosage |
|
Adults: Oral: 5 mg under the tongue or in the buccal pouch 3 times/day or 10
mg before meals or food, chewed 3 times/day, increasing in 2-3 days if needed.
Dosages of up to 100 mg/day are tolerated. Some patients may need bedtime doses
if they experience nocturnal symptoms. |
|
|
Dietary
Considerations |
|
Should be administered before meals |
|
|
Cardiovascular
Considerations |
|
Concomitant use of sildenafil (Viagra®) may precipitate
acute hypotension, myocardial infarction, or death. Nitrates used in right
ventricular infarction may induce acute hypotension. Nitrate use in severe
pericardial effusion may reduce cardiac filling pressure and precipitate cardiac
tamponade. |
|
|
Mental Health: Effects
on Mental Status |
|
May cause restlessness or dizziness |
|
|
Mental Health:
Effects on Psychiatric
Treatment |
|
Hypotensive effects may be exacerbated by low potency antipsychotic
(chlorpromazine) and TCAs |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
Do not change brands without consulting physician or pharmacist; notify
physician if persistent headache, dizziness, or flushing occurs; seek medical
help if chest pain is unresolved after 15 minutes; do not chew or swallow
sublingual tablet |
|
|
Nursing
Implications |
|
Do not crush sublingual drug product
Monitor blood pressure reduction for maximal effect and orthostatic
hypotension |
|
|
Dosage Forms |
|
Tablet, oral or sublingual: 10
mg |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|